Dermatologist Survey Lacked Details, Choices To Support Neutrogena ‘#1 Recommended’ Claim
J&J Consumer's Arguments Rejected Again In Industry Self-Regulation Forum
Executive Summary
J&J failed to convince BBB National Program’s appeals panel a 2008 NAD decision supporting its “#1 dermatologist recommended” claim for Neutrogena should preclude another review. Panel says market has changed in 12 years since review of Unilever challenge and L’Oreal could make its own challenge.